An exciting new field in medical research is opening up. Called metallomics, it centres on the role that metal elements in our bodies (iron, magnesium and the like) play in our health.
More effective treatment is needed for many childhood cancers, few more so than high-risk neuroblastoma, a very aggressive and difficult-to-treat tumour found in young children and babies which kills more than 50% of those diagnosed.
Groundbreaking research from our Leukaemia Biology Program has revealed how acute lymphoblastic leukaemia can become resistant to a class of anti-cancer drugs called glucocorticoids.
A database of genetic information of more than 270 cancer models, encompassing 25 different childhood cancers, has just been made publicly available. Children’s Cancer Institute contributed 90 leukaemia models to this global effort.
We presented exciting results from preclinical drug testing at a cancer conference this week in the US.
How we got to now in our understanding of MRP1, a protein that ejects chemotherapy drugs from tumour cells and stops them stopping cancer. We're exploring future drugs that target it.
In this second post in our series for Childhood Cancer Awareness month, see how we apply the basics about childhood cancer to search for better treatments.
September is International Childhood Cancer Awareness month. This month on our blog, every Wednesday, see how research gets translated from bench to bedside.
PhD student Ashleigh Fordham tells how her mum's diagnosis with breast cancer was the catalyst for her future career - a scientist curing cancer.
In the second post in a series profiling our emerging researchers, we meet Dr Han Shen who's researching treatments for children with a terrible cancer.